Dear DF/HCC Colleagues,
I wanted to bring your attention to an event series titled, "Equity by Design in Clinical Research: Cancer Clinical Trials" with more details below. This event series begins on March 8th and continues weekly until the last session on April 14th. I have had the pleasure of working with Dr. Barbara Bierer (BWH/MRCT/Catalyst) and a fantastic planning committee to design this course. Please see below for the schedule, course info, and registration link. I hope you find this topic compelling and I would love to see you join up. 
-Tim 
 Timothy Rebbeck, PhD
Co-Associate Director, Equity and Engagement,
Dana-Farber/Harvard Cancer Center

Click here to register now
REGISTER NOW!
The MRCT Center, in partnership with the Center for Cancer Equity and Engagement at the Dana-Farber/Harvard Cancer Center (DFHCC), is pleased to offer a six-part online training course entitled Equity by Design in Clinical Research: Cancer Trials. The course focuses on best practices for diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized.
This virtual course is a six-part series. One module will be presented each week from 4:30-6:00 pm EST (on alternating Tuesdays and Thursdays) for six weeks. All modules will begin with 45 minutes of instruction, followed by 45 minutes of discussion with leaders in the field. Attendees are encouraged to attend all sessions but are not required to do so.
Equity by Design in Clinical Research: Cancer Trials
  • 3/8/22 - Module 1: Commitment to DEI
  • 3/17/22 - Module 2: Community Engagement and Representation
  • 3/22/22 - Module 3: Study Planning and Communications
  • 3/31/22 - Module 4: Study Conduct
  • 4/5/22 - Module 5: Workforce Development
  • 4/14/22 - Module 6: Accountability, Advocacy, and Justice
We invite you to learn more about the course and to register. CME credits will be available.
Click here to register now
Subscribe to our email list.